PDCD1 and neoplasm: Recent work by others has demonstrated that certain tumour antigens, termed inhibigens, can suppress antitumour efficacy of cancer vaccines and anti-PD1 (ref. 56), and that their inhibitory function was due to their inherent but undefined structural characteristics.